globe life inc. - GL
GL
Close Chg Chg %
121.68 0.45 0.37%
Closed Market
122.13
+0.45 (0.37%)
Volume: 591.77K
Last Updated:
Jul 18, 2025, 3:59 PM EDT
Company Overview: globe life inc. - GL
GL Key Data
| Open $121.34 | Day Range 120.83 - 122.38 |
| 52 Week Range 86.10 - 133.76 | Market Cap $10.04B |
| Shares Outstanding 82.54M | Public Float 82.01M |
| Beta 0.56 | Rev. Per Employee N/A |
| P/E Ratio 9.89 | EPS $12.36 |
| Yield 81.41% | Dividend $0.27 |
| EX-DIVIDEND DATE Jul 3, 2025 | SHORT INTEREST N/A |
| AVERAGE VOLUME 621.00K |
GL Performance
| 1 Week | 3.35% | ||
| 1 Month | 1.24% | ||
| 3 Months | 0.69% | ||
| 1 Year | 38.33% | ||
| 5 Years | 51.91% |
GL Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
14
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 147.083 | |
| Number of Ratings | 14 | Current Quarters Estimate | 3.865 | |
| FY Report Date | 09 / 2025 | Current Year's Estimate | 13.683 | |
| Last Quarter’s Earnings | 3.25 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 12.37 | Next Fiscal Year Estimate | 14.925 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 11 | 11 | 12 | 12 |
| Mean Estimate | 3.87 | 3.49 | 13.68 | 14.92 |
| High Estimates | 4.08 | 3.66 | 13.94 | 15.15 |
| Low Estimate | 3.46 | 3.36 | 13.38 | 14.70 |
| Coefficient of Variance | 4.97 | 2.28 | 1.13 | 0.98 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 9 | 8 | 8 |
| OVERWEIGHT | 1 | 0 | 0 |
| HOLD | 4 | 4 | 6 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Globe Life Inc. - GL
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Globe Life Inc. - GL
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Jun 19, 2025 | Frank M. Svoboda Co-Chairman & CEO; Director | 134,898 | Bona fide gift | 0.00 |
| Jun 19, 2025 | Frank M. Svoboda Co-Chairman & CEO; Director | 139,898 | Bona fide gift | 0.00 |
| Mar 21, 2025 | Michael Shane Henrie SVP & Chief Accounting Officer | 1,820 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $123.39 per share | 224,569.80 |
| Mar 21, 2025 | Michael Shane Henrie SVP & Chief Accounting Officer | 3,250 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 21, 2025 | Michael Shane Henrie SVP & Chief Accounting Officer | 7,368 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $121.75 per share | 897,054.00 |
| Mar 21, 2025 | Michael Shane Henrie SVP & Chief Accounting Officer | 3,040 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $126.41 per share | 384,286.40 |
| Mar 21, 2025 | Michael Shane Henrie SVP & Chief Accounting Officer | 5,790 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $103.23 per share | 597,701.70 |
| Mar 21, 2025 | Michael Shane Henrie SVP & Chief Accounting Officer | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 21, 2025 | Michael Shane Henrie SVP & Chief Accounting Officer | 6,000 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 6, 2025 | Philip M. Jacobs Director | 1,183 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 6, 2025 | Matthew J. Adams Director | 1,183 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 6, 2025 | Robert E. Hensley EVP & Chief Investment Officer | 10,193 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $124.82 per share | 1,272,290.26 |
| Mar 3, 2025 | Michael Clay Majors EVP - Chief Strategy Officer | 45,681 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $121.93 per share | 5,569,884.33 |
| Mar 3, 2025 | Michael Clay Majors EVP - Chief Strategy Officer | 47,066 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | Michael Clay Majors EVP - Chief Strategy Officer | 12,800 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | Robert B. Mitchell EVP, General Counsel and CRO | 9,519 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | Robert B. Mitchell EVP, General Counsel and CRO | 6,764 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $121.93 per share | 824,734.52 |
| Mar 3, 2025 | Robert B. Mitchell EVP, General Counsel and CRO | 8,074 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | Frank M. Svoboda Co-Chairman & CEO; Director | 50,471 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | James Matthew Darden Co-Chairman & CEO; Director | 50,818 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |